FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileImricor Medical Systems, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
IMR.AX
Imricor Medical Systems, Inc. Stock AnalysisComprehensive stock analysis for Imricor Medical Systems, Inc. (IMR.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisIMR.AX
IMR.AX
Imricor Medical Systems, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
IMR.AX
  1. Home
  2. Stocks
  3. Imricor Medical Systems, Inc.

Imricor Medical Systems, Inc.

🇦🇺IMR.AX•ASX

Imricor Medical Systems, Inc.

🇦🇺IMR.AX•ASX

Your view on IMR.AX

Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Imricor Medical Systems, Inc.

Industry
Medical - Specialties
Sector
Healthcare
CEO
Steven Wedan
Headquarters
400 Gateway Boulevard, Burnsville, MN, US
Industry
Medical - Specialties
Sector
Healthcare
CEO
Steven Wedan
Headquarters
400 Gateway Boulevard, Burnsville, MN, US
Description

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company’s products include Vision-MR Ablation Catheter 2.

0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatible diagnostic catheter; NorthStar mapping system, a real-time, high-resolution soft tissue imaging of MRI to guide and visualize procedures with exceptional clarity; and Advantage-MR EP Recorder / Stimulator.

It also offers Vision-MR Dispersive Electrode to minimize eddy currents induced on the device’s conductive pads during mr scanning. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Imricor Medical Systems, Inc.. Starting points for Imricor Medical Systems, Inc.: EPS -AUD 0.12, beta 0.46 — an Medical - Specialties name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Imricor Medical Systems, Inc.. Imricor Medical Systems, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Imricor Medical Systems, Inc.. Trailing twelve-month EPS for Imricor Medical Systems, Inc. stands at -AUD 0.12. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 20, 2026 · USD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Earnings Estimate

EPSCurrent QtrMar 2024Next QtrJun 2024Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$0.00$0.00−$0.09−$0.07
Low estimate$0.00$0.00−$0.12−$0.10
High estimate$0.00$0.00−$0.07−$0.04
No. of analysts0033
Year-ago EPS——−$0.091—
Growth————

1Year-ago EPS includes one-time items; growth not shown.

Revenue Estimate

RevenueCurrent QtrMar 2024Next QtrJun 2024Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$596997.00$5.12M$1.57M$9.33M
Low estimate$596997.00$5.12M$433306.00$8.02M
High estimate$596997.00$5.12M$2.46M$11.47M
No. of analysts1134
Year-ago revenue——$302502.00—
Growth——+417.6%—

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 20, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Imricor Medical Systems, Inc.. Imricor Medical Systems, Inc. has reported as a listed company since 2019. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold IMR.AX12 companies · 3 funds
More Medical - Specialties companies
TickerTypeCompanySectorExchangeMkt cap
ACAISafeplus International Holdings LimitedHealthcareOTC$477
ADLIAmerican Medical Technologies Inc.HealthcareOTC$1,031
AIMVAI Maverick Intel, Inc.HealthcareOTC$3.0M
ALCAlcon Inc.HealthcareNYSE$36.2B
ANIKAnika Therapeutics, Inc.HealthcareNASDAQ$182.4M
APYXApyx Medical CorporationHealthcareNASDAQ$104.9M
ASFXAmerican Scientific Resources, IncorporatedHealthcareOTC$7,001
AVTIAvitar, Inc.HealthcareOTC$1,382
BEATHeartBeam, Inc.HealthcareNASDAQ$21.6M
BEATWHeartBeam, Inc.HealthcareNASDAQ$6.6M
BIELBioElectronics CorporationHealthcareOTC$7.2M
BMGPBiomagnetics Diagnostics Corp.HealthcareOTC$1,265
ETFs holding Imricor Medical Systems, Inc.
TickerFundFund assets% of the fund
VAS.AXVanguard Australian Shares Index ETF$27.0B in assets0.02%
ISO.AXiShares S&P/ASX Small Ordinaries ETF$120M in assets0.18%
SSO.AXState Street SPDR S&P/ASX Small Ordinaries ETF$24M in assets0.19%

Largest holders first, then the funds most concentrated in IMR.AX.

Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Imricor Medical Systems, Inc.. Coverage tracks Imricor Medical Systems, Inc. within Medical - Specialties (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Imricor Medical Systems, Inc.

IMR.AX AnalysisFair
Past
5
Growth
1
Health
3
Profit
1
Value
1

News

Latest Market News